A5101783385- Cancer survivorship and care
- Childhood Cancer Survivors' Quality of Life
- Palliative Care and End-of-Life Issues
- Family Support in Illness
- Economic and Financial Impacts of Cancer
- Ethics in medical practice
- Cancer-related cognitive impairment studies
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Treatment and Pharmacology
- Ethics in Clinical Research
- Patient Dignity and Privacy
- Head and Neck Cancer Studies
- Ethics and Legal Issues in Pediatric Healthcare
- Advances in Oncology and Radiotherapy
- Ocular Oncology and Treatments
- Brain Metastases and Treatment
- Neutropenia and Cancer Infections
- Reproductive Biology and Fertility
- Acute Lymphoblastic Leukemia research
- Colorectal Cancer Screening and Detection
- Lung Cancer Diagnosis and Treatment
- Biomedical Ethics and Regulation
- Statistical Methods in Clinical Trials
- Patient-Provider Communication in Healthcare
- Multiple and Secondary Primary Cancers
National Coalition for Cancer Survivorship
2014-2022
National Health Laboratory Service
2021
Memorial Sloan Kettering Cancer Center
2009-2019
Cornell University
2011-2018
Duke University
2018
University of Central Florida
2016
University of Arizona
2016
Survivorship A to Z
2016
St. Jude Children's Research Hospital
2013-2015
University of Colorado Cancer Center
2014-2015
We chose to examine the impact of socioeconomic factors on accrual National Cancer Institute (NCI)-sponsored cancer treatment trials.We estimated geographic and demographic burden in United States then identified 24,332 patients accrued NCI-sponsored trials during a 12-month period. Next, we examined by age, sex, residence, health insurance status, maintenance organization market penetration, several proxy measures availability an oncologist, presence hospital with approved multidisciplinary...
Over the past several decades, number of cancer survivors has increased dramatically as a result improved early detection first malignancies and effective therapies. There are more than 13 million in United States today.1 This is expected to reach 18 by 2022.1 These data underscore public health magnitude survivorship importance efforts characterize address concerns survivors. Although population heterogeneous, many face distinct serious care issues. Cancer at risk for long-term morbidity...
Previous reviews of phase 1 oncology trials reported a rate response to treatment 4 6 percent and toxicity-related death 0.5 percent. These results may not reflect the rates in current trials.We reviewed all nonpediatric sponsored by Cancer Therapy Evaluation Program at National Institute between 1991 2002. We report treatment, stable disease, grade toxic events, treatment-related deaths.We analyzed 460 involving 11,935 participants, whom were assessed for toxicity 10,402 therapy. The...
Purpose Tracking symptoms related to treatment toxicity is standard practice in routine care and during clinical trials. Currently, clinicians collect symptom information via complex often inefficient mechanisms, but there growing interest collecting outcome directly from patients. Patients Methods The National Cancer Institute Common Terminology Criteria for Adverse Events schema seven common was adapted into a Web-based patient-reporting system, accessible desktop computers outpatient...
In cancer treatment trials, clinicians traditionally report patient toxicity symptoms. Alternatively, patients could provide this information directly.The Common Terminology Criteria for Adverse Events (CTCAE) is the mandated instrument tracking symptoms in National Cancer Institute (NCI)-sponsored trials. We adapted CTCAE symptom items into language and uploaded these to an online platform. Lung outpatients receiving chemotherapy were invited self-report selected at visits via waiting area...
Many cancer survivors experience physical and/or psychosocial side effects, which can be severe, debilitating, and sometimes permanent. These NCCN Guidelines for Survivorship provide screening, evaluation, treatment recommendations common consequences of health care professionals who work with adult-onset in the posttreatment period. introductory sections guidelines include panel's definition survivors, a discussion effects its treatment, general principles standards survivorship care,...
The National Cancer Policy Forum of the Academies Sciences, Engineering and Medicine sponsored a workshop on July 24 25, 2017 Long-Term Survivorship after Treatment. brought together diverse stakeholders (patients, advocates, academicians, clinicians, research funders, policymakers) to review progress ongoing challenges since Institute (IOM)'s seminal report subject adult cancer survivors published in 2006. This commentary profiles content meeting sessions concludes with recommendations that...
Background The impact of cancer and its treatment on employment financial burden in adolescents/young adults (AYAs) is not fully known. Methods Eligibility for this cross‐sectional study AYA survivors included the diagnosis a malignancy between ages 18 39 years survey completion within 1 to 5 from ≥1 year after therapy completion. Participants were selected randomly tumor registries 7 participating sites completed an online patient‐reported outcomes assess concerns. Treatment data abstracted...
The current mechanism for monitoring toxicity symptoms in cancer trials depends on a complex paper-based process. Electronic collection of patient-reported outcomes (PROs) may be more efficient and accurate. An online PRO platform was created including simple data entry interface, real-time report generation, an alert system to e-mail clinicians when patients self-report serious toxicities. Feasibility assessment involving 180 chemotherapy demonstrated high levels use at up 40 follow-up...
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations common consequences of cancer treatment. They are intended to aid health care professionals who work with survivors adult-onset in the posttreatment period, including those general oncology, specialty survivor clinics, primary practices. Guidance is also provided help promote physical activity, weight management, proper immunizations survivors. This article summarizes panel's discussions 2016...
Although the number of long-term cancer survivors has increased substantially over past years, journey survivorship does not always include high-quality, patient-centered care. A variety care models have evolved based on who provides this care, survivor population, site and/or capacity for delivering specific services. Other areas being explored how long follow-up is needed, application a risk-based approach to and role in his or her own recovery. However, there little evidence indicating...
Journal Article Quality of Life in Phase II Trials: a Study Methodology and Predictive Value Patients With Advanced Breast Cancer Treated Paclitaxel Plus Granulocyte Colony-Stimulating Factor Get access Andrew D. Seidman, Seidman * Gynecological Medicine Service, Division Solid Tumor Oncology, Department Medicine, Memorial Sloan-Kettering CenterNew York, NY Correspondence to : M.D., Sloan-Kenering Center, 1275 York Ave., New 10021. Search for other works by this author on: Oxford Academic...
BACKGROUND The Institute of Medicine recommended that survivors cancer and their primary care providers receive survivorship plans (SCPs) to summarize treatment plan ongoing care. However, the use SCPs remains limited. METHODS Oncology at 14 National Cancer Community Centers Program hospitals completed a survey regarding perceptions SCPs, including barriers implementation, strategies for role oncology providers, importance topics in (diagnosis, treatment, care, aspects practice will...
Abstract The National Cancer Survivorship Resource Center (The Center) began in 2010 as a collaboration between the American Society and George Washington University Institute was funded by Centers for Disease Control Prevention. aims to improve overall health quality of life posttreatment cancer survivors. One key addressing needs this ever‐growing population is develop clinical follow‐up care guidelines that emphasize not only importance surveillance recurrence, but also address assessment...
This study demonstrates improvements in perceived knowledge and quality of survivorship care after receipt a comprehensive plan.
Although the number of long-term cancer survivors has increased substantially over past years, journey survivorship does not always include high-quality, patient-centered care. A variety care models have evolved based on who provides this care, survivor population, site and/or capacity for delivering specific services. Other areas being explored how long follow-up is needed, application a risk-based approach to and role in his or her own recovery. However, there little evidence indicating...